qPCR Reagents Market

Global qPCR Reagents Market Size (2022 to 2027)

The global qPCR reagents market size is estimated to be worth USD 1.76 billion in 2022 and is forecasted to be growing at a CAGR of 7.75% to reach USD 2.55 billion by 2027.

A qPCR is also known as a real-time polymerase chain reaction, and it is a laboratory method of molecular biology dependant on the polymerase chain reaction. It involves screening the magnification of a specific DNA segment while the polymerase chain reaction is undergoing. It can be applied in two variations, the semi-quantitative real-time polymerase chain reaction and quantitative real-time polymerase chain reaction. Applications of qPCR include gene expression, gene typing, miRNA analysis, pre-amplification, and virus detection. The process is usually carried out in a thermal cycler, which can illuminate each sample with a light beam of at least one specified wavelength. In addition, the thermal cycler can rapidly heat and chill samples.

MARKET DRIVERS:

The growth of the global qPCR Reagents market is mainly driven by factors such as the increasing patient population affected by genetic disorders and other infectious diseases, the growing geriatric population, and the advancements in technology in the life sciences domain.

Other contributors to the growth rate include the rising funding flowing in from the public and private sector and conferences and workshops held on the topic. In addition, growing market penetration in emerging countries and moving from plant-derived to genome-based drug discovery generate profitable market opportunities. The global qPCR reagents market growth is further driven by increasing public and private investment, funding and grants for PCR-based research, and the success of the human genome project.

Increasing penetration of international life science companies in the qPCR reagents market, growing policy focus on improved understanding of gene-based disease diagnosis and treatment, increased governmental and non-governmental funding for developing new qPCR technologies, and supporting cancer research provide growth opportunities to the market.

MARKET RESTRAINTS:

The technical limitations associated with qPCR and lack of technical expertise to operate qPCR equipment are the major factors restraining the market growth. In addition, the high cost of qPCR is expected to impede market growth.

Impact of COVID-19 on the global qPCR reagents market:

The introduction of the new coronavirus (COVID-19) has rapidly developed during the pandemic period. The global qPCR reagents market has seen an acceleration in growth due to COVID-19. The continuous COVID­19 pandemic endures establishing demand on diagnostic screening. RT-PCR AND qPCR reagents are used to conduct sample tests to confirm the COVID-19 status in a person. qPCR is one of the qualitative recognitions of nucleic acids from SARS-CoV-2. The potentiality of RT-qPCR is examined for recognizing at least one single positive sample with a huge count of negative examples. However, the qPCR is a high-cost assay and is unavailable for most diagnostic centers and laboratories worldwide. Nonetheless, With the support of COVID-19, the global qPCR market is expected to grow at a much better pace during the forecast period.

REPORT COVERAGE:

This research report on the global qPCR reagents market has been segmented and sub-segmented based on detection method, packaging type, application, end-user, and region.

qPCR Reagents Market – By Detection Method:

• Dye-Based qPCR Reagents
• Probes and Primer-Based qPCR Reagents 

Based on the detection method, the Probe-based qPCR reagents segment is anticipated to dominate with the highest growth rate during the forecast period. It offers many advantages, such as multiplexing, which can be used to detect different targets simultaneously.

qPCR Reagents Market – By Packaging Type:

• qPCR Core Kits
• qPCR Mastermixes

The segment of qPCR Core Kits is expected to lead the global qPCR reagents market by packaging type during the forecast period. Factors such as low prices for core kits (as opposed to Mastermixes), versatility for end-users (as it is best suited for researchers to build independent response protocols), and growing private-public funding for life science research are strongly favoring this segment.

qPCR Reagents Market – By End User:

• Hospitals & Diagnostic Centre
• Research Laboratories & Academic Institutes
• Pharmaceutical and Biotechnology Companies
• Clinical Research Organizations
• Forensic Laboratories

The hospital and diagnostic centers segment is expected to account for the leading share in the global qPCR reagents market based on End-User. Due to strengthening the healthcare system for successful diagnosis and treatment of diseases, increasing qPCR reagents for diagnostic applications, and other advantages offered by qPCR.

qPCR Reagents Market – By Application:

• Diagnostic
• Research
• Forensic

Based on the application, the research application is projected to dominate the market between 2021 to 2026. It will continue to be dominant in the forecast period due to widespread use in research areas such as stem cells, microbiology, and agriculture.

qPCR Reagents Market – By Region:

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East and Africa

Geographically, the global qPCR reagents market was dominated by North America in 2019, with the region accounting for 38% of the overall market share. North America was followed next in line by Europe and Asia-Pacific. Asia-Pacific is expected to grow rapidly in the coming years, as is evident from the high CAGR value for the region. Another market that shows promise in the coming years in Latin America.

The North American market is strongly driven by the availability of advanced healthcare infrastructure, increasing public and private investments, and pharmaceutical and biotechnology companies. In the regional market, the United States recorded the largest share of the qPCR reagents market, and it is anticipated to witness a predominant share during the forecast period. This is because of the technological advances in the life sciences sector, increasing healthcare spending, and favorable reimbursement policies. On the other hand, the Canadian qPCR reagents market is projected to showcase a considerable share in the coming years.

The European market was the second-largest shareholding region in the global qPCR reagents market in 2020. The occurrence of infectious diseases, increasing research and development activities, and accomplishment of human genome projected are fuelling the market growth. In addition, the emerging countries in the region such as Germany, the UK, Spain, Italy, and France are expanding the European regional market with a significant market share. Germany accounts for the largest share of the European qPCR reagents market owing to the technological developments in life sciences sectors, the presence of key market payers, and the prevalence of chronic diseases.

On the other hand, the Asia Pacific has been one of the fastest-growing regions globally in the qPCR reagents market over the years. However, it is anticipated to grow at a rapid pace during the forecast period. The market growth is expected to be driven by improving the healthcare sector, raising awareness related to gene-based disease treatment, and expanding the geriatric population. Moreover, highly populated emerging countries such as China and India are contributing to the APAC regional market growth.  Over the forecast period, China held the largest share of the qPCR market and more likely witnessed a prominent share during the forecast period. In addition, the growing geriatric population, increasing prevalence of infectious diseases, and growing life sciences industries boost the market growth. 

KEY MARKET PLAYERS:

A few promising companies in the global qPCR reagents market profiled in this report are Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen N.V., F. Hoffmann-La Roche Agilent Technologies Inc., Takara Bio, Affymetrix Inc., Promega Corporation, Sigma-Aldrich Corporation, and Quanta Biosciences.

KEY HAPPENINGS IN THIS MARKET IN THE RECENT PAST:

• In February 2020, Enzo Biochem announced that its wholly-owned subsidiary, Enzo Clinical labs, has received New York State approval for CT/NG/TV tests using liquid-based cytology sample collection on its proprietary GenFlex Platform. As a result, it is an available sample to result in the molecular diagnostic platform. 
• In February 2020, Promega Corporation, a global biotechnology manufacturer, launched its Wizard HMW DNA Extraction Kit for research working with large fragments of genomic DNA. 
• In December 2019, Promega Corporation announced that it had signed a deal with MilliporeSigma, a global leader in genome editing, to access MilliporeSigma’s foundational CRISPR genome editing technology. As a result, it will create new research products for investing in endogenous biology.  
• On November 06, 2019, Promega Corporation announced that it has entered into a collaboration with Merck to develop Promega’s microsatellite instability technology as an on-label, solid tumor diagnostic for Merck’s anti-PD-1 therapy KEYTRUDA. 
• On March 31, 2016, Thermo Fisher completed the acquisition process of Affymetrix.